APOE and type 2 diabetes mellitus: The proteins in HDLs are significantly modified in T2DM patients with increased levels of serum amyloid A, fibrinogen, ApoC2 and ApoC3 levels as well as reduced levels of ApoA1, ApoA2, ApoE, ApoM and PON1 (32, 33).